Complete Blood Count (CBC)
A complete blood count (CBC) is one of the initial tests performed when leukemia is suspected. This blood test provides valuable information about the types and numbers of cells present in the blood. By examining the levels of red blood cells, white blood cells, and platelets, doctors can identify abnormalities that may indicate leukemia. Abnormal counts may include lower red blood cell counts, higher or lower white blood cell counts, or low platelet counts.
Bone Marrow Aspiration and Biopsy
A bone marrow aspiration and biopsy are invasive procedures performed to collect bone marrow samples for analysis. During a bone marrow aspiration, a small needle is inserted into the bone to extract a liquid sample containing bone marrow cells. This sample is then examined under a microscope to evaluate the presence of leukemia cells. In a biopsy, a larger needle is used to retrieve a small core of bone and marrow tissue for further examination.
Cytogenetic Analysis
Cytogenetic analysis involves studying the chromosomes within leukemia cells. This test helps identify specific genetic abnormalities known as chromosomal mutations or translocations that are often associated with different types of leukemia. By analyzing the chromosomes, doctors can determine the severity of the leukemia, predict the response to treatment, and develop a targeted therapy plan.
Flow Cytometry
Flow cytometry is a technique used to assess the characteristics of cells, including their size, shape, and protein expression. In the case of leukemia, this test can help identify abnormal cells and determine their type. By tagging the cells with fluorescent markers and passing them through a flow cytometer, doctors can analyze multiple characteristics simultaneously, aiding in the accurate diagnosis of leukemia.
Molecular Testing
Molecular testing involves the analysis of DNA and RNA within leukemia cells. It allows doctors to identify specific genetic mutations or changes that play a significant role in the development and progression of leukemia. Detecting these mutations can help guide treatment decisions and determine the prognosis of the disease.
In conclusion, a combination of diagnostic tests is essential in accurately diagnosing and evaluating leukemia. The complete blood count, bone marrow aspiration and biopsy, cytogenetic analysis, flow cytometry, and molecular testing all contribute to determining the presence of leukemia, identifying the specific type and genetic abnormalities, and developing a tailored treatment plan. If you suspect you or a loved one may have leukemia, it is vital to consult a healthcare professional who can guide you through the diagnostic process and provide appropriate care.